In trading on Friday, shares of Autoliv Inc (Symbol: ALV) crossed below their 200 day moving average of $118.22, changing hands as low as $117.95 per share. Autoliv Inc shares are currently trading off about 2% on the day. The chart below shows the one year performance of ALV

The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpensive.

In this series, we look through the most recent Dividend Channel ''DividendRank'' report, and then we cherry pick only those companies that have experienced insider buying within the past six months. The officers and directors of a company tend to have a unique insider's view of

In trading on Friday, shares of Sensient Technologies Corp. (Symbol: SXT) crossed above their 200 day moving average of $99.61, changing hands as high as $101.27 per share. Sensient Technologies Corp. shares are currently trading up about 3.4% on the day. The chart below shows

President Trump demanded on Friday that U.S. government agencies cut their existing ties with generative artificial intelligence company Anthropic ( ANTHRO ) amid a dispute over how its AI models are used. “The Leftwing nut jobs at Anthropic have made a DISASTROUS MISTAKE trying to STRONG-ARM the Department of War, and force them to obey their Terms of Service instead of our Constitution,” the president wrote on Truth Social. “Their selfishness is putting AMERICAN LIVES at risk, our Troops in danger, and our National Security in JEOPARDY. Therefore, I am directing EVERY Federal Agency in the United States Government to IMMEDIATELY CEASE all use of Anthropic’s technology. We don’t need it, we don’t want it, and will not do business with them again! There will be a Six Month phase out period for Agencies like the Department of War who are using Anthropic’s products, at various levels. Anthropic better get their act together, and be helpful during this phase out period, or I will use the Full Power of the Presidency to make them comply, with major civil and criminal consequences to follow.” Anthropic on Thursday said that the company “cannot in good conscience” allow the Department of Defense to use its models in all lawful use cases without limitation, adding that the agency’s threats do not change its position. “It is the Department’s prerogative to select contractors most aligned with their vision,” CEO Dario Amodei wrote in a statement . “But given the substantial value that Anthropic’s technology provides to our armed forces, we hope they reconsider.” “Partially autonomous weapons, like those used today in Ukraine, are vital to the defense of democracy. Even fully autonomous weapons (those that take humans out of the loop entirely and automate selecting and engaging targets) may prove critical for our national defense. But today, frontier AI systems are simply not reliable enough to power fully autonomous weapons. We will not knowingly provide a product that puts ...

美股三大指数集体收跌，道指跌1.05%，纳指跌0.92%，标普500指数跌0.43%。大型科技股多数下跌，英伟达跌超4%，苹果跌逾3%，微软跌超2%，特斯拉、Meta跌超1%；奈飞逆势涨超13%，谷歌涨超1%，亚马逊小幅上涨。银行股重挫，高盛跌逾7%，摩根士丹利跌超6%，富国银行、花旗集团跌超5%，美国银行跌超4%。

Key Points178,188 shares added; estimated trade value of $11.07 million (based on average quarterly prices).

Earnings Call Insights: American Healthcare REIT (AHR) Q4 2025 Management View Jeffrey Hanson, Chairman and Interim CEO & Interim President, began by addressing the leadership transition, stating "I stepped into the role of Interim CEO, while Danny is on a medical leave of absence. I'm pleased to share that he's at home recovering well and is in good spirits... He intends to return in the relative near term, but it's too early to have timing visibility at this point." Hanson emphasized "This is a seamless continuation of the strategy and execution you've grown to expect from this team... There's no change in strategy. Our investment in capital allocation strategy, risk management framework, balance sheet posture and long-term value orientation remain unchanged." Gabriel Willhite, Chief Operating Officer, highlighted "the fourth quarter capped off another exceptional year of outsized NOI growth for AHR. We delivered total portfolio same-store NOI growth of 11.8% in the fourth quarter and 14.2% for the full year 2025." Willhite credited the operating portfolio, especially the Trilogy and SHOP segments, for this performance, noting "same-store occupancy reached 90.6% in Q4, up 275 basis points year-over-year." Stefan K. Oh, Chief Investment Officer, reported "We closed on over $950 million of new investments across our Trilogy and SHOP segments... The majority of our acquisition volume this year was within SHOP, where we added newer assets in attractive submarkets... our SHOP segment as the second largest within our diversified portfolio in terms of cash NOI." Brian Peay, Chief Financial Officer, stated "We reported normalized funds from operations attributable to common stockholders, or NFFO of $0.46 per diluted share in the fourth quarter of 2025 and $1.72 per diluted share for all of 2025. That represents 22% year-over-year NFFO per share growth in 2025 as compared to 2024." Outlook Brian Peay outlined 2026 guidance, stating "we issued 2026 NFFO guidance of $1.99 to...

Getty Images Investment Thesis The iShares U.S. Pharmaceuticals ETF ( IHE ) trades at 15.69x forward earnings and holds stocks that, in aggregate, are expected by analysts to increase their earnings per share by 19.07% over the next twelve months. From a GARP perspective, it doesn't get much better than that, and IHE is also supported by positive earnings revisions according to Seeking Alpha Quant Factor Grades. These are examples of the important fundamental boxes IHE checks, why it's on an impressive nine-month winning streak, and why I've decided to issue it a "buy" rating. I hope you enjoy the read, and as always, I look forward to your questions in the comments section afterward. IHE Overview According to its website , IHE tracks the Dow Jones U.S. Select Pharmaceuticals Index , which is currently comprised of 55 U.S. stocks involved in the manufacturing or prescription of over-the-counter drugs or the production of vaccines. In this industry, the market is extremely concentrated, which is why the Index's float-adjusted market-cap-weighting scheme results in more than 45% allocated to just two stocks: Johnson & Johnson ( JNJ ) and Eli Lilly and Company ( LLY ). Other top stocks include Merck & Co., Inc. ( MRK ), Bristol-Myers Squibb Company ( BMY ), and Viatris Inc. ( VTRS ), and based on IHE's ~80% allocation to the following top ten holdings, it's a pretty non-diversified product. For me, that's okay, though, as the purpose is tactical rather than strategic. iShares Key fund characteristics for IHE include a 0.38% expense ratio and $1.03 billion in assets under management amassed since its May 1, 2006, inception date. It's not that much, but IHE is merely one fund in a larger suite of sector/industry ETFs offered by iShares, so as a group, it's successful. As benchmarks today, I'll analyze IHE alongside the iShares U.S. Healthcare ETF ( IYH ) and the iShares Russell 3000 ETF ( IWV ), with the goal of highlighting how IHE is fundamentally stronger than the bro...

2月28日热门中概股多数下跌， 纳斯达克 中国金龙指数（HXC）收跌1.81%。 上涨股当中（按市值从高到低）， 日月光半导体 涨0.29%，携程涨0.67%， 中华电信 涨0.26%， 联电 涨1.27%， 中通 涨1.01%，小马智行涨0.99%，拓臻生物涨2.93%， 金山云 涨6.98%， 雾芯 科技涨0.63%。 下跌股当中（按市值从高到低）， 台积电 跌0.56%， 阿里 巴巴 跌2.69%， 拼多多 跌1.58%， 网易 跌0.41%， 百度 跌0.57%， 京东 跌1.67%， 腾讯音乐 跌0.98%， 富途 控股跌2.92%， 贝壳 跌1.05%， 理想 汽车跌1.73%， 华住酒店集团 跌2.25%，小鹏汽车跌1.13%， 蔚来 跌4.32%， 哔哩哔哩 跌2.00%，中国新城农村跌3.74%，满帮跌1.52%， 新东方 跌1.95%， 唯品会 跌3.84%，万国数据跌1.15%，BOSS直聘跌1.47%，WSP控股跌2.67%，名创优品跌0.93%，亚朵集团跌2.97%， 慧荣科技 跌1.41%， 华视 传媒 跌1.40%，欢聚跌5.00%，微牛跌3.33%。 美股周五收跌，三大股指在本周均录得跌幅。英伟达公布财报后，其股价连续第二个交易日下跌。知名软件股普跌。最新生产者价格指数数据远超预期，显示美国通胀仍具粘性，加重了引发市场动荡的担忧情绪。 瑞银 下调美国股票市场评级。 道指跌521.28点，跌幅为1.05%，报48977.92点；纳指跌210.17点，跌幅为0.92%，报22668.21点；标普500指数跌29.98点，跌幅为0.43%，报6878.88点。 领涨中概股列表： 领跌中概股列表： （截图来自新浪财经APP 行情-美股-中概股热门板块）下载新浪财经APP 责任编辑：张俊 SF065

The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends of the investing world.

Shares of leading cannabis-focused real estate investment trust (REIT) Innovative Industrial Properties (NYSE: IIPR) are up 16% this week as of 3 p.m. ET on Friday after the company announced fourth-quarter earnings. While revenue and funds from operations (FFO) each declined 13% in Q4, these figures easily exceeded Wall Street's expectations, helping push shares higher. A lot of this slowdown stems from litigation tied to defaults will that keep resolving with time, so the drop in revenue and FFO is worse than it really is, and the market responded accordingly. Not to mention the fact that IIP's shares are down 73% over the last five years, so there wasn't an incredible high hurdle for the stock to jump over in Q4. Now paying a staggering 13.9% dividend yield, the company needs FFO to start rebounding at some point to maintain its current payout level. However, Chairmen of the Board and co-founder Alan Gold is optimistic, explaining: We're seeing strong releasing activity which is driving revenue ... and we have the resolutions of some of these major lease litigations. And with those resolutions, and the activity, the leasing activity we're seeing, we continuously feel positive about where we are with regards to our dividend. Continue reading

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo

Eric Broder Van Dyke Live Nation Entertainment ( LYV ) fell 9% in after-hours trading on a report that multiple efforts by the company to settle a federal antitrust lawsuit have been rebuffed by the government ahead of a trial next week. Live Nation ( LYV ) has been trying to settle the antitrust case for months, according to a Bloomberg report on Friday, which cited people familiar with the matter. Jury selection for the trial is set for Monday, and a trial could last six weeks. The lack of progress means that any settlement before next week is highly unlikely, according to the report. Negotiations remain ongoing, and there's still a possibility that a settlement could be reached during or after the trial. DOJ and Live Nation didn’t immediately respond to Bloomberg's requests for comment. The lawsuit, which was filed in 2024, alleges Live Nation ( LYV ) deepened its power and influence in multiple parts of the live events industry. More on Live Nation Entertainment Live Nation Entertainment, Inc. (LYV) Q4 2025 Earnings Call Transcript Live Nation: Lawsuit Uncertainty And Lofty Valuations Make Me Pass On It Live Nation: Deceleration Fears Are Becoming A Reality Live Nation signals double-digit AOI growth in 2026 while expanding global venue footprint Live Nation's increased ticket sales and concert revenue narrows operating loss

LAGUNA HILLS, Calif., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Elite Express Holding Inc. (“ETS” or the “Company”) (Nasdaq CM: ETS), a California-based provider of last-mile delivery services, today reported results for the financial year ended November 30, 2025 and provided a corporate update.

Many, if not most of us are in the market for promising stocks that will boost our wealth over time. It can be hard to zero in on the best ones, though -- especially if we feel we don't have the time, skills, or inclination to study the universe of stocks. Enter index funds . They tend to charge low fees if you buy them in exchange-traded fund (ETF) form. (An ETF is a fund that trades like a stock, making it easy to get in and out of.) If you invest in a good S&P 500 index fund, for example, you'll quickly be a part owner of 500 of America's biggest companies. That's powerful, as the S&P 500 and the overall stock market have notched average annual gains of close to 10% over many decades. Image source: Getty Images. Continue reading

Apple Inc Stock Closed Down by 3.42% on Feb 27: Facts Behind the Movement TradingKey

watch now VIDEO 1:28 01:28 Trump tells U.S. government to stop using Anthropic's technology Closing Bell President Donald Trump said Friday that he was ordering every U.S. government agency to "immediately cease" using technology from the artificial intelligence company Anthropic . Trump's abrupt and unexpected order came as the AI startup faces pressure by the Defense Department to comply with demands that it can use the company's technology without restrictions sought by Anthropic. The company wants the Pentagon to assure it that the AI models will not be used for fully autonomous weapons or mass domestic surveillance of Americans. The Pentagon had set a deadline of 5:01 p.m. ET Friday for Anthropic to agree to its demands allowing the Pentagon to use the technology for all lawful purposes. If Anthropic did not meet that deadline, Pete Hegseth threatened to label the company a "supply chain risk" or force it to comply by invoking the Defense Production Act. "The Leftwing nut jobs at Anthropic have made a DISASTROUS MISTAKE trying to STRONG-ARM the Department of War, and force them to obey their Terms of Service instead of our Constitution," Trump said in a post on Truth Social. "Their selfishness is putting AMERICAN LIVES at risk, our Troops in danger, and our National Security in JEOPARDY." "Therefore, I am directing EVERY Federal Agency in the United States Government to IMMEDIATELY CEASE all use of Anthropic's technology," Trump wrote. "We don't need it, we don't want it, and will not do business with them again!" There will be a Six Month phase out period for Agencies like the Department of War who are using Anthropic's products, at various levels," Trump said. Anthropic CEO Dario Amodei said that his company "cannot in good conscience" allow the Pentagon to use its models without limitation. This is breaking news. Please refresh for updates.

Paramount Skydance Corp.’s $111 billion bid for Warner Bros. Discovery Inc. will strain its credit rating , an S&P Global Ratings analyst said, even if the combined company could ultimately cut its debt levels over time. S&P Global Ratings has a BB+ rating for Paramount Skydance, the highest junk level. The entertainment company this week clinched a deal for Warner Bros. Discovery, outmaneuvering Netflix Inc. after a months-long battle. “The amount of debt this combined company will have is enormous, something like $80 billion, and given what leverage will look like for this combined company, it’s pretty obvious that there’s a lot of pressure on this rating,” said Naveen Sarma , an analyst at S&P, in an interview with Bloomberg on Friday. “The leverage would be higher than what is acceptable for this rating.” Depending on the final terms of the financing, leverage — the company’s debt relative to a measure of earnings — could end up being 7 times or more, Sarma estimated. But to keep its BB+ rating, the company would probably need to keep its leverage below 4.5 times, he said. Paramount’s planned purchase will be financed in part with $57.5 billlion of debt from Bank of America Corp., Citigroup Inc. and Apollo Global Management Inc. Sarma said the combined entity could reduce leverage by selling assets that will overlap, such as TV production facilities and studio lots, and cutting costs.

格隆汇2月28日｜美国国务院：我们再次呼吁目前身处伊朗的美国公民立即离境。

【有線新聞】意大利米蘭有電車出軌，高速撞向建築物，至少2人死亡，包括一名60歲途人，另外有54人受傷。警方正循誤殺方向調查。 行車紀錄儀片段拍到事發一刻，一輛電車行駛期間突然車身搖晃，先後向兩邊傾例，再失控出軌，高速撞向附近建築物。電車撞毀一間餐廳的落地玻璃，再衝入店內，碎片散落一地，車身損毀。 事發在周五下午4時許，意大利米蘭一架9號線電車駛經米蘭市中心威尼斯門附近時出軌。救援部門派出10多架救護車和消防車到場，並在附近搭建帳篷治理傷者。有救援人員登上電車，救出被困乘客，當局指1名乘客送院後傷重不治，另有1名60歲途人被電車撞倒後死亡，電車司機和多名乘客受傷，部分人傷勢嚴重。 入夜後搜救工作持續，警方封鎖現場調查。意大利傳媒報道涉事電車由三節車卡組成，當局初步調查顯示事發時電車車速過快，司機供稱當時感到不適，正循誤殺和疏忽導致他人死亡方向調查。 米蘭市長薩拉到場視察，指事件涉及人為失誤，認為司機可能在路軌的分岔位未有確保電車繼續直線行駛，而導致意外；又說電車出事前曾經跳站，形容事件是悲劇，總理梅洛尼向遇難者致哀。

According to a February 17, 2026, SEC filing , Clearline Capital LP reduced its position in Semtech (NASDAQ:SMTC) by 412,968 shares during the fourth quarter of 2025. The fund’s quarter-end position in Semtech was valued at $21.07 million, a $28.87 million decrease from the previous quarter, reflecting both share sales and price changes. This transaction was a sale. Following the trade, the position represents 1.04% of Clearline’s 13F reportable assets under management. Top holdings after the filing: Continue reading

Coba ETC 3x Silver Daily Long I (X0CM.SG) 風險 Yahoo 財經

格隆汇2月28日｜美国国务院：伊朗政权必须停止扣押人质，并立即释放所有在伊朗被不公正拘留的美国公民。伊朗采取措施将有助于解除美国当前对它的制裁指定及相关行动。

格隆汇2月28日｜美国国务院：任何美国公民均不应以任何理由前往伊朗。

Source: Bloomberg, 5:52

格隆汇2月28日｜美国国务院：伊朗被认定为支持非法拘禁的国家。

Amazon.com (AMZN) Data Center Push Continues with $12B Investment in Louisiana Insider Monkey

Apple to Purchase 100M Chips from Taiwan Semiconductor Manufacturing (TSM) Arizona Facility Insider Monkey

财联社2月28日讯（编辑 史正丞） 最新市场传闻称，世界首富马斯克的民营航天公司SpaceX正考虑最快于3月秘密递交首次公开募股文件。 作为今年三大潜在IPO（SpaceX、OpenAI、Anthropic）中最确定的一家，此举将与其6月完成IPO的目标保持步调一致。通过秘密交表，拟上市公司可以在招股书公之于众前，先获得监管机构的反馈意见并进行修改。 据知情人士透露， SpaceX可能会在IPO中寻求“超过1.75万亿美元”的估值 。按照发稿时的市场情况推算，这意味着SpaceX能够力压Meta和沙特阿美，在全球市值排行榜中位列第7。 （来源：companiesmarketcap） 此前报道显示，在2月初SpaceX收购xAI的交易中，合并后新实体的整体估值为1.25万亿美元。 知情人士称，相关的考虑仍在进行中，具体的细节仍有可能发生改变，SpaceX仍有可能推迟提交招股书。 与此前消息一致， 知情人士称SpaceX的IPO募资规模可能高达500亿美元 。这将大幅超越目前的世界纪录——沙特阿美2019年创下的290亿美元。SpaceX曾在一份备忘录中表示，筹资目的包括为“星舰”火箭提供“疯狂的发射频率”、在太空建立人工智能数据中心，以及建设月球基地。 若不出意外，与马斯克关系密切的摩根士丹利，以及华尔街头部银行摩根大通、高盛和美国银行将出任SpaceX上市的主承销行。SpaceX有可能会采用“同股不同权”的股权结构，赋予马斯克等内部人士更多投票权。